Back to Search
BRYAN AUNGST, DMD
DMD
Dentist
NPI: 1356432124Individual
Specialties, Licenses & Credentials
DentistPrimary
Dentist
Code: 122300000X
DS029429L(PA)
Research & Publications (14)
Formulation and food effects on the oral absorption of a poorly water soluble, highly permeable antiretroviral agent.
PMID 12115838·J Pharm Sci·2002
7-preclinical
The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds.
PMID 11145221·Pharm Res·2000
8-other
Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
PMID 16457995·Eur J Pharm Sci·2006
7-preclinical
Relationship between loperamide-induced sedative effect and digoxin pharmacokinetics in healthy Japanese subjects.
PMID 15835747·Pharm Res·2005
4-observational
Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction.
PMID 15359582·Pharm Res·2004
4-observational
Beta-cyclodextrin as a suitable solubilizing agent for in situ absorption study of poorly water-soluble drugs.
PMID 15265550·Int J Pharm·2004
4-observational
In vitro permeation of beta-lactam antibiotics across rat jejunum and its correlation with oral bioavailability in humans.
PMID 12392595·Br J Clin Pharmacol·2002
7-preclinical
Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 beta-cyclodextrin (SBE 7) complexes.
PMID 12115827·J Pharm Sci·2002
4-observational
Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells.
PMID 11913542·Biol Pharm Bull·2002
8-other
Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa.
PMID 11170646·J Med Chem·2001
7-preclinical
Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.
PMID 11033075·Eur J Pharm Sci·2000
7-preclinical
The de novo design and synthesis of cyclic urea inhibitors of factor Xa: optimization of the S4 ligand.
PMID 10698459·Bioorg Med Chem Lett·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4579 E PLEASANT VALLEY BLVD
TYRONE, PA 16686 - Phone
- (814) 684-9455
Quick Facts
- NPI
- 1356432124
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile